Hodgkin lymphoma is characterized by an extensively dominant tumor microenvironment (TME) composed of different types of noncancerous immune cells with rare malignant cells. Characterization of the cellular components and their spatial relationship is crucial to understanding cross-talk and therapeutic targeting in the TME. We performed single-cell RNA sequencing of more than 127,000 cells from 22 Hodgkin lymphoma tissue specimens and 5 reactive lymph nodes, profiling for the first time the phenotype of the Hodgkin lymphoma–specific immune microenvironment at single-cell resolution. Single-cell expression profiling identified a novel Hodgkin lymphoma–associated subset of T cells with prominent expression of the inhibitory receptor LAG3, and...
Contains fulltext : 161837.pdf (publisher's version ) (Open Access)Tumor-infiltrat...
International audienceAbstract The outcome of classical Hodgkin lymphoma (cHL) patients may be relat...
The clinical success of cancer immune checkpoint blockade (ICB) has refocused attention on tumor-inf...
Hodgkin lymphoma is characterized by an extensively dominant tumor microenvironment (TME) composed o...
Hodgkin lymphoma is a unique malignancy in which reactive immune cells vastly outnumber the tumor ce...
Funder: National Nature Science Foundation of China 81922058 National Science and Technology Major P...
Classical Hodgkin’s lymphoma (cHL) accounts for 10% of all lymphoma diagnosis. The peculiar feature ...
Classic Hodgkin lymphoma (cHL) is a unique lymphoid neoplasm characterized by extensive immune infil...
Two papers published in this edition of Cancer Cell (Zheng et al., 2022 and Veatch et al., 2022) pro...
Background: Hodgkin's lymphoma (HL) is characterised by an ineffective immune response that is predo...
Therapeutic blockade of PD-1/PD-L1 shows promising results in Hodgkin’s lymphoma (HL) and in s...
Contains fulltext : 161837.pdf (publisher's version ) (Open Access)Tumor-infiltrat...
International audienceAbstract The outcome of classical Hodgkin lymphoma (cHL) patients may be relat...
The clinical success of cancer immune checkpoint blockade (ICB) has refocused attention on tumor-inf...
Hodgkin lymphoma is characterized by an extensively dominant tumor microenvironment (TME) composed o...
Hodgkin lymphoma is a unique malignancy in which reactive immune cells vastly outnumber the tumor ce...
Funder: National Nature Science Foundation of China 81922058 National Science and Technology Major P...
Classical Hodgkin’s lymphoma (cHL) accounts for 10% of all lymphoma diagnosis. The peculiar feature ...
Classic Hodgkin lymphoma (cHL) is a unique lymphoid neoplasm characterized by extensive immune infil...
Two papers published in this edition of Cancer Cell (Zheng et al., 2022 and Veatch et al., 2022) pro...
Background: Hodgkin's lymphoma (HL) is characterised by an ineffective immune response that is predo...
Therapeutic blockade of PD-1/PD-L1 shows promising results in Hodgkin’s lymphoma (HL) and in s...
Contains fulltext : 161837.pdf (publisher's version ) (Open Access)Tumor-infiltrat...
International audienceAbstract The outcome of classical Hodgkin lymphoma (cHL) patients may be relat...
The clinical success of cancer immune checkpoint blockade (ICB) has refocused attention on tumor-inf...